Yali Fu

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański et al. · New England Journal of Medicine · 2018 · 3.1K citations · Full text

Validation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire Disorder

Leonard R. Derogatis, Anita H. Clayton, Diane J. Lewis-D’Agostino et al. · The Journal of Sexual Medicine · 2007 · 716 citations

Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor–Resistant <i>EGFR</i> -Mutant Lung Cancer with and without T790M Mutations

Yelena Y. Janjigian, Egbert F. Smit, Harry J.M. Groen et al. · Cancer Discovery · 2014 · 354 citations · Full text

Activity of Afatinib/Cetuximab in Patients (PTS) with EGFR Mutant Non-Small Cell Lung Cancer (Nsclc) and Acquired Resistance (Ar) To EGFR Inhibitors

Y. Y. Janjigian, Egbert F. Smit, Leora Horn et al. · Annals of Oncology · 2012 · 49 citations · Full text

Medicine, Pharmacology, Pathology +6

Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE

H.-J. Song, Jingyi Cheng, S.-L. Hu et al. · Clinical Radiology · 2014 · 35 citations · Full text

Positron Emission Tomography, 18F-fdg Pet/ct, Hepatology +12